|
6:30 – 7:30 a.m. |
Registration and Breakfast
|
|
7:30 – 7:45 a.m.
|
Welcome and Introduction
Henry A. Nasrallah, MD
|
|
7:45 – 8:45 a.m.
|
Is There a Rational Algorithm for the Pharmacotherapy of Major Depression?
Michael Thase, MD
|
|
8:45 – 9:45 a.m.
|
Mood Stabilizer or Atypical Antipsychotic: What to Use in First Episode VS Multiple Episode Bipolar Mania?
Roger McIntyre, MD
|
|
9:45 – 10:00 a.m.
|
Break/Exhibits |
|
10:00 – 11:00 a.m.
|
Neuroinflammation and Oxidative Stress During Acute Episodes: Implications for the Pharmacotherapy of Schizophrenia, Bipolar Disorder and Major Depression
Henry A. Nasrallah, MD
|
|
11:00 – 12:00 p.m.
|
Long-acting Injectable Antipsychotics and Clozapine: From Under-use to Best Practice
Peter Weiden, MD
|
|
12:00 – 1:30 p.m.
|
Luncheon Symposium (non-CME)
|
|
1:30 – 1:45 p.m.
|
Dessert Break/Exhibits |
|
1:45 – 2:45 p.m.
|
Should Benzodiazepines Be Used At All: What is the Best Practice for the Treatment of Anxiety?
James Jefferson, MD |
|
2:45 – 3:45 p.m.
|
An Update on the Best Practice to Manage Eating Disorders
Anne Marie O'Melia, MS, MD, FAAP
|
|
3:45 – 4:00 p.m.
|
Break/Exhibits
|
|
4:00 – 5:00 p.m.
|
The Emerging Role of Omega-3 Fatty Acid in the Treatment of Major Psychiatric Disorders.
Robert McNamara, PHD
|
|
5:00 – 5:30 p.m.
|
Review of Key Points and Conclusions
|
|
5:30 p.m.
|
Adjournment
|
Agenda is subject to change. Please check back for updates.
|